+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Alzheimer Disease Drugs Markets in China

  • ID: 836803
  • Report
  • Region: China
  • 239 pages
  • AMID Co
1 of 4
China's demand for Alzheimer's Disease Drugs will continue to grow at 10% by 2028
China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

These market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, these research reports provide the insights and projections into Chinese markets necessary for you to do so.
Note: Product cover images may vary from those shown
2 of 4
I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. ALZHEIMER’S DISEASE DRUGS INDUSTRY ASSESSMENTS
  • Alzheimer's Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development
IV. ALZHEIMER’S DISEASE DRUGS PRODUCTION AND DEMAND
  • Overview
  • Demand of Alzheimer's Disease Drugs by Region
  • Alzheimer's Disease Drugs Sales Volume
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • Other Alzheimer's Disease Drugs
  • Alzheimer's Disease Drugs Imports
  • Ginkgo Bilota Extract Imports
  • Breviscapine Imports
  • Ganglioside Imports
  • Donepezil Imports
  • Galanthamine Imports
  • Nicergoline Imports
  • Rivastigmine Imports
  • Memantine Imports
  • Huperzine A Imports
  • Oxiracetam Imports
  • Flunarizine Imports
  • Piracetam Imports
  • Other Alzheimer's Disease Drugs Imports
  • Pricing Trend
V. ALZHEIMER’S DISEASE DRUGS MARKET OUTLOOK
  • Alzheimer's Disease Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends By Region
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
V. MARKETING STRATEGIES
  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E- commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises
VII. ALZHEIMER’S DISEASE DRUGS PRODUCER DIRECTORY
  • Major Alzheimer’s Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End- Users
LIST OF TABLES

I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. ALZHEIMER’S DISEASE DRUGS INDUSTRY ASSESSMENTS
  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Alzheimer's Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments
IV. ALZHEIMER’S DISEASE DRUGS PRODUCTION AND DEMAND
  • Total Alzheimer's Disease Drugs Sales Volume
  • Alzheimer's Disease Drugs Major Producer and Their Market Share
  • Ginkgo Bilota Extract Major Producer and Their Market Share
  • Breviscapine Major Producer and Their Market Share
  • Ganglioside Major Producer and Their Market Share
  • Donepezil Major Producer and Their Market Share
  • Galanthamine Major Producer and Their Market Share
  • Dihydroergotamine Major Producer and Their Market Share
  • Rivastigmine Major Producer and Their Market Share
  • Memantine Major Producer and Their Market Share
  • Huperzine A Major Producer and Their Market Share
  • Oxiracetam Major Producer and Their Market Share
  • Flunarizine Major Producer and Their Market Share
  • Piracetam Major Producer and Their Market Share
  • Alzheimer's Disease Drugs Import
V. ALZHEIMER’S DISEASE DRUGS MARKET OUTLOOK
  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
LIST OF CHARTS

I. INTRODUCTION
  • Alzheimer's Disease Drugs Sales Volume
II. BUSINESS ENVIRONMENT
  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China’s Imports and Exports
III. ALZHEIMER’S DISEASE DRUGS INDUSTRY ASSESSMENTS
  • Alzheimer's Disease Drugs Sales Volume
II. ALZHEIMER’S DISEASE DRUGS PRODUCTION AND DEMAND
  • Alzheimer's Disease Drugs Sales Volume
  • Worldwide Alzheimer's Disease Drugs Demand by Region
  • Ginkgo Bilota Extract Sales Volume and Market Share
  • Breviscapine Sales Volume and Market Share
  • Ganglioside Sales Volume and Market Share
  • Donepezil Sales Volume and Market Share
  • Galanthamine Sales Volume and Market Share
  • Dihydroergotamine Sales Volume and Market Share
  • Rivastigmine Sales Volume and Market Share
  • Memantine Sales Volume and Market Share
  • Huperzine A Sales Volume and Market Share
  • Oxiracetam Sales Volume and Market Share
  • Flunarizine Sales Volume and Market Share
  • Piracetam Sales Volume and Market Share
  • Other Alzheimer's Disease Drugs Sales volume and market share
  • Alzheimer's Disease Drugs Import Volume
  • Ginkgo Bilota Extract Import Volume and Market Share
  • Breviscapine Import Volume and Market Share
  • Ganglioside Import Volume and Market Share
  • Donepezil Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Dihydroergotamine Import Volume and Market Share
  • Rivastigmine Import Volume and Market Share
  • Memantine Import Volume and Market Share
  • Huperzine A Import Volume and Market Share
  • Oxiracetam Import Volume and Market Share
  • Flunarizine Import Volume and Market Share
  • Piracetam Import Volume and Market Share
  • Other Alzheimer's Disease Drugs Import Volume and Market Share
VI. MARKETING STRATEGIES
  • China’s Distribution Channel
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Hainan Zambon Pharmaceutical Co., Ltd
  • Liaoning Dalian Pfizer Pharmaceutical Co., Ltd
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll